Clinical trial
D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD
NCT00356278 · Emory University, Other · Completed
Key facts
| NCT number | NCT00356278 |
|---|---|
| Title | D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD |
| Official title | A Cognitive Enhancer May Facilitate Behavioral Exposure Therapy for Veterans With PTSD |
| Lead sponsor | Emory University, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Stress Disorder, Post Traumatic |
| Intervention type | Behavioral, Drug |
| Interventions | D-Cycloserine, Alprazolam, Virtual Reality Exposure Therapy, Placebo |
| Enrollment | 156 |
| Start date | Sep 1, 2006 |
| Primary completion | Jun 1, 2014 |
| Completion | Jun 1, 2014 |
| First posted | Jul 25, 2006 |
| Last update posted | Jan 8, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: